Abhinav Karan

Abhinav Karan

Auto-generated profile, based on publicly available information

Abhinav Karan

Internal Medicine, University of Florida College of Medicine – Jacksonville, Jacksonville, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Global Health Research and Policy
Verified
Journal Article
Open access
PDF file
AKAbhinav Karan
Abhinav Karan
KAKabeer Ali
Kabeer Ali
STSurujpal Teelucksingh
Surujpal Teelucksingh
Sateesh SakhamuriSateesh Sakhamuri
Sateesh Sakhamuri
Air pollution is the most significant environmental risk factor for all-cause mortality, and it has caused substantial disability-adjusted life-years and economic loss. Air pollution intensified the mortality during past pandemics, Spanish flu in 1918 and SARS-CoV-1 in 2003. It increases host susceptibility and virulence of respiratory infections and reduces viral clearance. Thus, a question arises whether there will be any impact of air pollution on the current pandemic coronavirus disease 2019 (COVID-19)? Thus far, history and science are directing towards an immense potential impact of air pollution on the COVID-19 pandemic. Some of the devastated countries with the current pandemic are those with a poor air quality index. Further epidemiological and ecological studies are necessary to confirm this association. Also, countries must mobilize funding for mitigation of air pollution to benefit environmental health and ameliorate its potential effects on pandemics of the future.

1 November 2020 in Medical Hypotheses
Verified
Journal Article
Closed access
AKAbhinav Karan
Abhinav Karan
KAKabeer Ali
Kabeer Ali
KRKirin Rambaran
Kirin Rambaran
PCPedro Del Corral
Pedro Del Corral
Sateesh SakhamuriSateesh Sakhamuri
Sateesh Sakhamuri
STSurujpal Teelucksingh
Surujpal Teelucksingh

13 July 2023 in Cureus
Verified
Journal Article
Open access
PDF file
AKAbhinav Karan
Abhinav Karan
NMNaji Maaliki
Naji Maaliki
WKWilliam M. Kogler
William M. Kogler
KEKhadeeja Esmail
Khadeeja Esmail
Propofol is a widely used general anesthetic agent with a generally familiar and predictable adverse effect profile. Severe left ventricular dysfunction to an ejection fraction of < 35% is a rare adverse effect of propofol, with a scarcity of data in the literature. In this case, we report a 36-year-old female at 36 weeks gestation with a prior remote history of peripartum cardiomyopathy, who, while receiving propofol for general anesthesia during a C-section, developed severe left ventricular dysfunction with an ejection fraction of 20-25%, flash pulmonary edema, and cardiogenic shock. She required initiation of inotropic support and, following weaning of propofol, gradually recovered her ejection fraction over the next 24 hours to 40-45% and to 50-55% at follow-up two weeks after discharge. This case highlights a unique adverse effect of propofol with scarce pre-existing literature and no guidelines on appropriate management. It is essential for clinicians to be familiar with this uncommon complication, particularly as propofol use continues to rise worldwide.

1 November 2023 in Journal of Geriatric Cardiology
Verified
Journal Article
Open access
PDF file
AKAbhinav Karan
Abhinav Karan
PCPranitha Chekka
Pranitha Chekka
PRPramod Reddy
Pramod Reddy
Ersistent methicillin-sensitive staphylococcus aureus (MSSA) bacteremia is usually defined as persistent bacteremia despite 7 days of appropriate antibiotic therapy. While nafcillin, cefazolin, or oxacillin are excellent antimicrobial options, persistent MSSA is a commonly encountered phenomenon in clinical practice for which further guidelines on appropriate management are necessitated. Here we highlight two cases of MSSA bacteremia requiring salvage therapy with ertapenem.

12 April 2022 in Cureus
Verified
Journal Article
Open access
AKAbhinav Karan
Abhinav Karan
AAAdefemi Adeyemo
Adefemi Adeyemo
MOMichael Omar
Michael Omar
KFKerolos Fahmi
Kerolos Fahmi
SSSrinivasan Sattiraju
Srinivasan Sattiraju
Acute myocardial infarction in a young patient is a nebulous entity, but in the absence of traditional cardiovascular risk factors, particular attention must be paid to thrombotic disorders and hypercoagulable states. A 28-year-old male presented with worsening substernal chest pain for 36 hours. He was recently diagnosed with systemic lupus erythematosus (SLE) with active class II lupus nephritis. With an initial electrocardiogram revealing ischemic changes, and an elevated troponin I, a concern was raised for myocardial infarction. Transthoracic echocardiography revealed a severely reduced ejection fraction of 25%, and a subsequent emergent left heart catheterization revealed a complete, massive thrombotic occlusion of the proximal left anterior descending artery, requiring aspiration thrombectomy. After extensive workup for hypercoagulable states, he was found to have elevated anticardiolipin IgG and IgM antibodies on two occasions, twelve weeks apart. The patient was managed with triple anticoagulation with aspirin, clopidogrel, and warfarin for one month, followed by dual anticoagulation with clopidogrel and warfarin with a targetted international normalized ratio (INR) of 2.0 - 3.0. The management of acute coronary syndrome caused by antiphospholipid syndrome (APS) is highly individualized and driven by clinician gestalt owing to the lack of a standardized consensus. While systemic thrombolysis, primary percutaneous coronary intervention (PCI), and coronary artery bypass grafting all have their utility, only a very small handful of case reports exist on the benefits of each. This particular case serves to showcase an instance where a patient was successfully managed with PCI with dual antiplatelet therapy. Further prospective randomized controlled trials are necessary to determine the optimal management of this rarely encountered patient population.

1 March 2022 in Annals of Internal Medicine: Clinical Cases
Verified
Journal Article
Closed access
AKAbhinav Karan
Abhinav Karan
MOMicheal Omar
Micheal Omar
GVGladys R. R Velarde
Gladys R. R Velarde
SSSrinivasan Sattiraju
Srinivasan Sattiraju
A retained angioplasty wire is rarely described, and there are no guidelines as to how it should be managed. Thus the management of this complication remains highly individualized. In the present i...